Showing results (301-310 of 361) with videos related to

Sort By:
Pageof 37
Antiviral Research|December 18, 2017
Research priorities for the discovery of a cure for chronic hepatitis B: Report of a workshopTimothy M Block, Harvey Alter, Nathaniel Brown, et al.
Nature Communications|September 6, 2022
In vivo adenine base editing reverts C282Y and improves iron metabolism in hemochromatosis miceAlice Rovai, BoMee Chung, Qingluan Hu, et al.
Antibiotics (Basel, Switzerland)|February 25, 2022
Canadian Collaboration to Identify a Minimum Dataset for Antimicrobial Use Surveillance for Policy and Intervention Development across Food Animal SectorsDavid F Léger, Maureen E C Anderson, François D Bédard, et al.
Stem Cells Translational Medicine|August 9, 2013
Sustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapyReto Eggenschwiler, Komal Loya, Guangming Wu, et al.
Cell Transplantation|February 4, 2006
Large-scale isolation of human hepatocytes for therapeutic applicationKrassimira Alexandrova, Carsten Griesel, Marc Barthold, et al.
Gut|August 3, 2021
The tumour microenvironment shapes innate lymphoid cells in patients with hepatocellular carcinomaBernd Heinrich, E Michael Gertz, Alejandro A Schäffer, et al.
Molecular Therapy. Methods & Clinical Development|September 11, 2023
Modifying immune responses to adeno-associated virus vectors by capsid engineeringMartin Bentler, Romain Hardet, Moritz Ertelt, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 4, 2016
Generation of Genetically Engineered Precursor T-Cells From Human Umbilical Cord Blood Using an Optimized Alpharetroviral Vector PlatformJuwita Hübner, Shahabuddin S Hoseini, Julia D Suerth, et al.
Journal of Hepatology|August 2, 2020
MicroRNA-342-3p is a potent tumour suppressor in hepatocellular carcinomaRonja-Melinda Komoll, Qingluan Hu, Olaniyi Olarewaju, et al.
Nature Medicine|March 3, 2026
In vivo base editing gene therapy for heterozygous familial hypercholesterolemia: a phase 1 trialPing Wan, Siyuan Tang, Dongni Lin, et al.
Pageof 37